Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

  • MWN109 1Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • MWN109 1Registry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(43%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 1
1
14%
Phase 2
5
71%
Phase 3
1
14%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
5(71.4%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(3)

Detailed Status

Completed3
Active, not recruiting2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 25 (71.4%)
Phase 31 (14.3%)

Trials by Status

not_yet_recruiting114%
completed343%
recruiting114%
active_not_recruiting229%

Recent Activity

3 active trials
Showing 5 of 7
completedphase_1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

NCT07787728
recruitingphase_2

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus

NCT07801820
active_not_recruitingphase_2

Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity

NCT07804797
completedphase_2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

NCT07791524
active_not_recruitingphase_2

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

NCT07791537
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07787728Phase 1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

Completed
NCT07801820Phase 2

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus

Recruiting
NCT07804797Phase 2

Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity

Active Not Recruiting
NCT07791524Phase 2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

Completed
NCT07791537Phase 2

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

Active Not Recruiting
NCT07791654Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

Completed
NCT07778693Phase 3

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

Not Yet Recruiting

All 7 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
7